Tianyong Shi

Title: Innovations by Tianyong Shi in Gene Therapy

Introduction

Tianyong Shi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of gene therapy, particularly in the treatment of retinal diseases. His innovative work has led to the development of a unique vector that holds promise for treating Bietti's crystalline dystrophy.

Latest Patents

Tianyong Shi holds a patent for a vector and method for treating Bietti's crystalline dystrophy. The patent describes a vector comprising a polynucleotide encoding CYP4V2 and a promoter operably linked to this polynucleotide. This vector demonstrates a good expression effect, high expression speed, and stable expression intensity. Additionally, the application provides cells, pharmaceutical compositions, and kits that include the vector, along with methods for treating, alleviating, and preventing diseases associated with retinal pigment epithelium (RPE) atrophy. He has 1 patent to his name.

Career Highlights

Tianyong Shi is associated with Chigenovo Co., Ltd., where he continues to advance his research in gene therapy. His work is pivotal in developing therapeutic solutions for retinal disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Tianyong has collaborated with notable colleagues, including Liping Yang and Shaohong Chen. Their combined expertise enhances the research and development efforts at Chigenovo Co., Ltd.

Conclusion

Tianyong Shi's innovative contributions to gene therapy, particularly in treating retinal diseases, highlight his role as a leading inventor in this field. His work continues to pave the way for advancements in medical treatments.